Who invested in Carmell Therapeutics?
Carmell Therapeutics's investors include Innovation Works, Pittsburgh Life Sciences Greenho, BlueTree Allied Angels, Harbor Light Capital Partners and Newlin Investment Company, and 1 more on record.
United States · Seed startup
7 rounds we have observed, with the 6 investors named in them. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.
Funding summaryUpdated 26 Oct 2026
$4.4Mraised across 7 rounds since 2008, from 7 sources
Each circle is a round, placed by date and sized by amount. The line above is the running total.
From a historical funding recordSEC filing: $137K sold, first sale Jul 2015
No investor was named in the report.
From a historical funding recordSEC filing: $137K sold, first sale Jul 2015
From a historical funding recordSEC filing: $304K sold, first sale Oct 2014
From a historical funding recordSEC filing: $681K sold, first sale Dec 2013
No investor was named in the report.
Reported by sec.govSEC filing: $411K sold, first sale Dec 2012
Reported by bizjournals.comSEC filing: $2.4M sold, first sale Apr 2011
The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.
Carmell Therapeutics's investors include Innovation Works, Pittsburgh Life Sciences Greenho, BlueTree Allied Angels, Harbor Light Capital Partners and Newlin Investment Company, and 1 more on record.
Carmell Therapeutics has raised $4.4M across 7 rounds since 2008. One round did not disclose an amount, so the total is a floor.
Carmell Therapeutics's most recent round was a Seed in Aug 2015.
Carmell Therapeutics's largest round on record is $2.4M (Series A), in Apr 2011.
Carmell Therapeutics's first round on record, in Jan 2008, was backed by Pittsburgh Life Sciences Greenho.
Carmell Therapeutics's latest named round is a Seed, in Aug 2015.
Carmell Therapeutics is based in the United States.
Search every investor by what they have actually funded, then narrow to your stage and market. Free.